February 11th 2025
CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to recapture the heights of old.
Enhancing the Industry's Reputation: A Four-Point Solution
January 6th 2015Following Pharm Exec’s recent profile of the Express Scripts CMO, Dr. Steve Miller adds some further thoughts - on health reform, cost-effectiveness research, pharma’s reputation, and the obligations of government - to his incisive critique of industry pricing practises.
The Medicines Adherence Challenge
December 1st 2011Keeping skittish patients on their medicines ought to be a strategic priority for Big Pharma - but is it? Pharm Exec convenes an expert round table to examine how best to make progress and agree on some practical steps for incorporation in the campaign agenda.